Development and Validation of a UPLC Method for Determination of Mirabegron in Tablet Dosage Forms
B. Anupama, A. Viswanath, . Azizunnisa & Md. Vaseemunnisa · Journal of Pharmaceutical Research International · 2022
Mirabegron is a drug that is used to treat an overactive bladder. Mirabegron activates the β3 adrenergic receptor in the bladder's detrusor muscle, causing muscular relaxation and bladder capacity expansion. A few measurement procedures have been discovered, but they are inconven...
Open access
Research Article
10.9734/jpri/2022/v34i42B36299